OCTP — Oxford Cannabinoid Technologies Holdings Share News
0.000.00%
Oxford Cannabinoid - MHRA & REC 2 Approval for Phase 1 Clinical Trial
UK's Oxford Cannabinoid Technologies gains as unit OCT renews licence
Brief: Oxford Cannabinoid Confirms Appointment Of Clarissa Sowemimo-Coker As Permanent CEO
Oxford Cannabinoid - Holding in Company
Oxford Cannabinoid - Half-year Report
Oxford Cannabinoid - Appointment of General Counsel & Notice of Results
Oxford Cannabinoid - Update on combined Clinical Trial Application
Oxford Cannabinoid - Submission of combined Clinical Trial Application
Oxford Cannabinoid - Second Price Monitoring Extn
Oxford Cannabinoid - Price Monitoring Extension
Oxford Cannabinoid - Second Price Monitoring Extn
Oxford Cannabinoid - Price Monitoring Extension
Oxford Cannabinoid - Second Price Monitoring Extn
Oxford Cannabinoid - Price Monitoring Extension
Oxford Cannabinoid - Second Price Monitoring Extn
Oxford Cannabinoid - Price Monitoring Extension
Oxford Cannabinoid - Director/PDMR Shareholding
Oxford Cannabinoid - Trading Update
Brief: Oxford Cannabinoid Technologies Says CEO John Lucas Will Step Down